Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ALBENDAZOLE vs TRICLABENDAZOLE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ALBENDAZOLE vs TRICLABENDAZOLE: Safety Overview

Metric ALBENDAZOLE TRICLABENDAZOLE
Total FAERS Reports 1,039 42
Deaths Reported 132 0
Death Rate 12.7% N/A
Hospitalizations 338 4
Average Patient Age 45.1 yrs 43.3 yrs
% Female Patients 40.1% 44.7%
FDA Approval Date Dec 14, 2018 Feb 13, 2019
Manufacturer Novadoz Pharmaceuticals LLC Novartis Pharmaceuticals Corporation
Route ORAL ORAL
Marketing Status Discontinued Prescription